Novartis Bioventures Ltd, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), sold 174,578 shares at $1.08 ($185K) on 2019-04-11, disclosed to the SEC on 2019-04-15.
Open-market sale of $185k ARPO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.08 | 57,438 | $62K | 33.6% |
| 2 | $1.08 | 57,438 | $62K | 33.6% |
| 3 | $1.04 | 30,908 | $32K | 17.4% |
| 4 | $0.99 | 28,794 | $29K | 15.4% |
| Total | $1.06 avg | 174,578 | $185K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-10 | $367K | — | Filing → |